State of Wyoming’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Buy
2,748
+1,815
+195% +$182K 0.03% 760
2025
Q4
$90.8K Sell
933
-75
-7% -$6.43K 0.01% 1325
2025
Q3
$71.7K Buy
+1,008
New +$67.2K 0.01% 1410
2025
Q2
Sell
-3,013
Closed -$158K 1978
2025
Q1
$158K Buy
3,013
+307
+11% +$17.2K 0.02% 943
2024
Q4
$149K Buy
+2,706
New +$142K 0.02% 1006
2024
Q1
Sell
-848
Closed -$40.3K 1725
2023
Q4
$40.3K Sell
848
-737
-46% -$31K 0.01% 1409
2023
Q3
$70.3K Buy
+1,585
New +$73.6K 0.02% 1086
2022
Q4
Sell
-2,007
Closed -$60K 1665
2022
Q3
$60K Sell
2,007
-571
-22% -$19.9K 0.03% 912
2022
Q2
$87K Buy
2,578
+1,422
+123% +$51K 0.05% 585
2022
Q1
$52K Buy
1,156
+634
+121% +$29.3K 0.03% 1033
2021
Q4
$24K Sell
522
-3
-0.6% -$121 0.01% 1422
2021
Q3
$18K Sell
525
-50
-9% -$1.7K 0.01% 954
2021
Q2
$17K Buy
+575
New +$15.8K 0.01% 954

Other funds holding IRMD

State of Wyoming's IRMD Position: Q1 2026 in Review

State of Wyoming increased its iRadimed (IRMD) stake by 195% in Q1 2026, buying an estimated $182K and bringing the position to 2,748 shares worth $265K. The position accounts for 0.03% of the portfolio, ranked #760.

State of Wyoming first reported a position in IRMD in Q2 2021 and has held it in 13 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • State of Wyoming held 2,748 shares of iRadimed worth $265K as of Q1 2026.
  • State of Wyoming bought 1,815 iRadimed shares in Q1 2026, an estimated $182K.
  • iRadimed made up 0.03% of State of Wyoming's portfolio in Q1 2026, its #760 holding.
  • State of Wyoming first reported a position in iRadimed in Q2 2021 and has held it in 13 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.